2012-10-05 17:24:25 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Klebsiella Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Klebsiella Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Klebsiella Infections. Klebsiella Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated

disease.

Scope

* A snapshot of the global therapeutic scenario for Klebsiella Infections.
* A review of the Klebsiella Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Klebsiella Infections pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468476_klebsiella_infections_pipeline_review ..


Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Klebsiella Infections.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Klebsiella Infections pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Klebsiella Infections Overview
Therapeutics Development
An Overview of Pipeline Products for Klebsiella Infections
Klebsiella Infections Therapeutics under Development by Companies
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Klebsiella Infections Therapeutics - Products under Development by Companies
Companies Involved in Klebsiella Infections Therapeutics Development
AlphaRx, Inc.
Rib-X Pharmaceuticals, Inc.
Orchid Chemicals & Pharmaceuticals Ltd
Achaogen Inc.
Phico Therapeutics Ltd.
Cantab Biopharmaceuticals Limited
Klebsiella Infections - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
plazomicin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ciprofloxacin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
RX-04 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SLP-0907 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SASPject PT3.X - Drug Profile
Product Description
Mechanism of Action
R&D Progress
OCID5090 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Gram-Negative Programme - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Snare Antibacterial For Gram Negative Infections - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Klebsiella Infections Therapeutics - Drug Profile Updates
Klebsiella Infections Therapeutics - Dormant Products
Klebsiella Infections - Product Development Milestones
Featured News & Press Releases
Jan 06, 2011: NovaBay Reports Activity Of NVC-422 Against Deadly Superbug Producing NDM-1
Mar 23, 2004: IMPAX Receives Final FDA Approval for Generic Version of Declomycin; Fifth ANDA Approval in 2004
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Klebsiella Infections, H2 2012
Products under Development for Klebsiella Infections - Comparative Analysis, H2 2012
Number of Products under Development by Companies, H2 2012
Comparative Analysis by Early Clinical Stage Development, H2 2012
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2012
Products under Development by Companies, H2 2012
AlphaRx, Inc., H2 2012
Rib-X Pharmaceuticals, Inc., H2 2012
Orchid Chemicals & Pharmaceuticals Ltd, H2 2012
Achaogen Inc., H2 2012
Phico Therapeutics Ltd., H2 2012
Cantab Biopharmaceuticals Limited, H2 2012
Assessment by Monotherapy Products, H2 2012
Assessment by Stage and Route of Administration, H2 2012
Assessment by Stage and Molecule Type, H2 2012
Klebsiella Infections Therapeutics - Drug Profile Updates
Klebsiella Infections Therapeutics - Dormant Products

List of Figures

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468476&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.